Skip to content

Parenteral Nutrition Support for Patients With Pancreatic Cancer

Parenteral Nutrition Support for Patients With Pancreatic Cancer. A Phase II Study.

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00919659
Enrollment
32
Registered
2009-06-12
Start date
2002-01-31
Completion date
2004-05-31
Last updated
2009-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer Cachexia, Pancreatic Cancer

Keywords

parenteral nutrition, cancer cachexia, pancreatic cancer

Brief summary

The purpose of this study is to determine whether the additional nutrition support is improving the nutritional status of patients suffering cancer caxechia or not.

Detailed description

To examine the impact of additional parenteral nutrition (APN) we prospective evaluated 32 pts suffering APC and progressive cachexia. This assay is based on a bioelectrical impedance analysis (BIA) as a proven tool for nutritional investigation in patients with chronic disease. Phase angle, determined by BIA, has been found to be a prognostic indicator in several chronic and malignant conditions, such as HIV, liver cirrhosis, chronic obstructive pulmonary disease lung cancer and pancreatic cancer.

Interventions

DIETARY_SUPPLEMENTparenteral nutrition

25kcal/kg bw with parenteral nutrition

Sponsors

Fresenius AG
CollaboratorINDUSTRY
CONKO-Studiengruppe
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* histological proved pancreatic cancer * progressive cancer cachexia * refractive to enteral supplementation * informed consent

Exclusion criteria

* prefinal status * septic disease

Design outcomes

Primary

MeasureTime frame
nutritional status presented by phase angle12 weeks

Secondary

MeasureTime frame
quantity of port infections, quantity of oedema, quantity of diarrhea12 weeks

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 1, 2026